Entero Therapeutics
- Country
- Ownership
- -
- Employees
- 9
- Market Cap
- -
- Introduction
First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm involves in therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, ...
Entero signs Letter of Intent to license and commercialize remote patient and machine vision
Entero Therapeutics to exclusively license Data Vault's QOLPOM and FotoDigm software for GI clinical trials, with plans to secure up to $3 million in strategic investment. The deal aims to improve clinical trial compliance and outcomes, leveraging Data Vault's technology for Entero's phase 3 latiglutenase trial for celiac disease.
© Copyright 2024. All Rights Reserved by MedPath